Early transplantation of an encapsulated glial cell line—derived neurotrophic factor—producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease

View More View Less
  • 1 Department of Neurological Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

Object. Glial cell line—derived neurotrophic factor (GDNF) has been shown to confer neuroprotective effects on dopaminergic neurons. The authors investigated the effects of GDNF on 6-hydroxydopamine (6-OHDA)—treated dopaminergic neurons in vitro and in vivo.

Methods. First, the authors examined how 1, 10, or 100 ng/ml of GDNF, administered to cells 24 hours before, simultaneously with, or 2 or 4 hours after 6-OHDA was added, affected dopaminergic neurons. In a primary culture of E14 murine ventral mesencephalic neurons, earlier treatment with the higher dosage of GDNF suppressed 6-OHDA—induced loss of dopaminergic neurons better than later treatment. Next, the authors examined whether continuous infusion of GDNF at earlier time points would demonstrate a greater neuroprotective effect in a rat model of Parkinson disease (PD). They established a human GDNF-secreting cell line, called BHK-GDNF, and encapsulated the cells into hollow fibers. The encapsulated cells were unilaterally implanted into the striatum of adult rats 1 week before; simultaneously with; or 1, 2, or 4 weeks after 6-OHDA was given to induce lesions of the same striatum. With the earlier transplantation of a BHK-GDNF capsule, there was a significant reduction in the number of amphetamine-induced rotations displayed by the animals. Rats that had received earlier implantation of BHK-GDNF capsules displayed more tyrosine hydroxylase—positive neurons in the substantia nigra pars compacta and a tendency for glial proliferation in the striatum.

Conclusions. These neuroprotective effects may be related to glial proliferation and signaling via the GDNF receptor α1. The results of this study support a role for this grafting technique in the treatment of PD.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1.

    Ai Y, , Markesbery W, , Zhang Z, , Grondin R, , Elseberry D, & Gerhardt GA, et al: Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects. J Comp Neurol 461:250261, 2003 Ai Y, Markesbery W, Zhang Z, Grondin R, Elseberry D, Gerhardt GA, et al: Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects. J Comp Neurol 461:250–261, 2003

    • Search Google Scholar
    • Export Citation
  • 2.

    Aoi M, , Date I, , Tomita S, & Ohmoto T: GDNF induces recovery of the nigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration. Acta Neurochir 142:805810, 2000 Aoi M, Date I, Tomita S, Ohmoto T: GDNF induces recovery of the nigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration. Acta Neurochir 142:805–810, 2000

    • Search Google Scholar
    • Export Citation
  • 3.

    Aoi M, , Date I, , Tomita S, & Ohmoto T: Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism. Restor Neurol Neurosci 17:3138, 2001 Aoi M, Date I, Tomita S, Ohmoto T: Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism. Restor Neurol Neurosci 17:31–38, 2001

    • Search Google Scholar
    • Export Citation
  • 4.

    Arjona V, , Minguez-Castellanos A, , Montoro RJ, , Ortega A, , Escamilla F, & Toledo-Aral JJ, et al: Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery 53:321330, 2003 Arjona V, Minguez-Castellanos A, Montoro RJ, Ortega A, Escamilla F, Toledo-Aral JJ, et al: Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery 53:321–330, 2003

    • Search Google Scholar
    • Export Citation
  • 5.

    Cohen AD, , Tillerson JL, , Smith AD, , Schallert T, & Zigmond MJ: Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem 85:299305, 2003 Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ: Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem 85:299–305, 2003

    • Search Google Scholar
    • Export Citation
  • 6.

    Cunningham LA, & Su C: Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Exp Neurol 174:230242, 2002 Cunningham LA, Su C: Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Exp Neurol 174:230–242, 2002

    • Search Google Scholar
    • Export Citation
  • 7.

    Date I, , Asari S, , Nishimoto A, & Felten DL: [Adrenal medullary graft induces recovery of the host nigrostriatal dopaminergic system in MPTP-induced mouse model of Parkinson's disease.] No To Shinkei 42:11731178, 1990 (Jpn) Date I, Asari S, Nishimoto A, Felten DL: [Adrenal medullary graft induces recovery of the host nigrostriatal dopaminergic system in MPTP-induced mouse model of Parkinson's disease.] No To Shinkei 42:1173–1178, 1990 (Jpn)

    • Search Google Scholar
    • Export Citation
  • 8.

    Date I, , Shingo T, , Yoshida H, , Fujiwara K, , Kobayashi K, & Takeuchi A, et al: Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats. Cell Transplant 10:397401, 2001 Date I, Shingo T, Yoshida H, Fujiwara K, Kobayashi K, Takeuchi A, et al: Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats. Cell Transplant 10:397–401, 2001

    • Search Google Scholar
    • Export Citation
  • 9.

    Eggert K, , Schlegel J, , Oertel W, , Wurz C, , Krieg JC, & Vedder H: Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro. Neurosci Lett 269:178182, 1999 Eggert K, Schlegel J, Oertel W, Wurz C, Krieg JC, Vedder H: Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro. Neurosci Lett 269:178–182, 1999

    • Search Google Scholar
    • Export Citation
  • 10.

    Freed CR, , Greene PE, , Breeze RE, , Tsai WY, , DuMouchel W, & Kao R, et al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710719, 2001 Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710–719, 2001

    • Search Google Scholar
    • Export Citation
  • 11.

    Gill SS, , Patel NK, , Hotton GR, , O'Sullivan K, , McCarter R, & Bunnage M, et al: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589595, 2003 Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, et al: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589–595, 2003

    • Search Google Scholar
    • Export Citation
  • 12.

    Hanbury R, , Ling ZD, , Wuu J, & Kordower JH: GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. J Comp Neurol 461:307316, 2003 Hanbury R, Ling ZD, Wuu J, Kordower JH: GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. J Comp Neurol 461:307–316, 2003

    • Search Google Scholar
    • Export Citation
  • 13.

    Harvey BK, , Chang CF, , Chiang YH, , Bowers WJ, , Morales M, & Hoffer BJ, et al: HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp Neurol 183:4755, 2003 Harvey BK, Chang CF, Chiang YH, Bowers WJ, Morales M, Hoffer BJ, et al: HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp Neurol 183:47–55, 2003

    • Search Google Scholar
    • Export Citation
  • 14.

    Hebb AO, , Hebb K, , Ramachandran AC, & Mendez I: Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage. J Neurosurg 98:10781083, 2003 Hebb AO, Hebb K, Ramachandran AC, Mendez I: Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage. J Neurosurg 98:1078–1083, 2003

    • Search Google Scholar
    • Export Citation
  • 15.

    Ikeda T, , Xia XY, , Xia YX, , Ikenoue T, , Han B, & Choi BH: Glial cell line-derived neurotrophic factor protects against ischemia/hypoxia-induced brain injury in neonatal rat. Acta Neuropathol 100:161167, 2000 Ikeda T, Xia XY, Xia YX, Ikenoue T, Han B, Choi BH: Glial cell line-derived neurotrophic factor protects against ischemia/hypoxia-induced brain injury in neonatal rat. Acta Neuropathol 100:161–167, 2000

    • Search Google Scholar
    • Export Citation
  • 16.

    Insua MF, , Garelli A, , Rotstein NP, , German OL, , Arias A, & Politi LE: Cell cycle regulation in retinal progenitors by glia-derived neurotrophic factor and docosahexaenoic acid. Invest Ophthalmol Vis Sci 44:22352244, 2003 Insua MF, Garelli A, Rotstein NP, German OL, Arias A, Politi LE: Cell cycle regulation in retinal progenitors by glia-derived neurotrophic factor and docosahexaenoic acid. Invest Ophthalmol Vis Sci 44:2235–2244, 2003

    • Search Google Scholar
    • Export Citation
  • 17.

    Kirik D, , Georgievska B, , Rosenblad C, & Bjorklund A: Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease. Eur J Neurosci 13:15891599, 2001 Kirik D, Georgievska B, Rosenblad C, Bjorklund A: Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease. Eur J Neurosci 13:1589–1599, 2001

    • Search Google Scholar
    • Export Citation
  • 18.

    Kordower JH: In vivo gene delivery of glial cell line—derived neurotrophic factor for Parkinson's disease. Ann Neurol 53 (Suppl 3):S120S134, 2003 Kordower JH: In vivo gene delivery of glial cell line—derived neurotrophic factor for Parkinson's disease. Ann Neurol 53 (Suppl 3):S120–S134, 2003

    • Search Google Scholar
    • Export Citation
  • 19.

    Kordower JH, , Palfi S, , Chen EY, , Ma SY, , Sendera T, & Cochran EJ, et al: Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol 46:419424, 1999 Kordower JH, Palfi S, Chen EY, Ma SY, Sendera T, Cochran EJ, et al: Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol 46:419–424, 1999

    • Search Google Scholar
    • Export Citation
  • 20.

    Lin LF, , Doherty DH, , Lile JD, , Bektesh S, & Collins F: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:11301132, 1993 Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130–1132, 1993

    • Search Google Scholar
    • Export Citation
  • 21.

    Marco S, , Saura J, , Perez-Navarro E, , Jose Marti M, , Tolosa E, & Alberch J: Regulation of c-Ret, GFRalpha1, and GFRalpha2 in the substantia nigra pars compacta in a rat model of Parkinson's disease. J Neurobiol 52:343351, 2002 Marco S, Saura J, Perez-Navarro E, Jose Marti M, Tolosa E, Alberch J: Regulation of c-Ret, GFRalpha1, and GFRalpha2 in the substantia nigra pars compacta in a rat model of Parkinson's disease. J Neurobiol 52:343–351, 2002

    • Search Google Scholar
    • Export Citation
  • 22.

    Maswood N, , Grondin R, , Zhang Z, , Stanford JA, , Surgener SP, & Gash DM, et al: Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys. Neurobiol Aging 23:881889, 2002 Maswood N, Grondin R, Zhang Z, Stanford JA, Surgener SP, Gash DM, et al: Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys. Neurobiol Aging 23:881–889, 2002

    • Search Google Scholar
    • Export Citation
  • 23.

    Nicole O, , Ali C, , Docagne F, , Plawinski L, , MacKenzie ET, & Vivien D, et al: Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J Neurosci 21:30243033, 2001 Nicole O, Ali C, Docagne F, Plawinski L, MacKenzie ET, Vivien D, et al: Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J Neurosci 21:3024–3033, 2001

    • Search Google Scholar
    • Export Citation
  • 24.

    Niwa H, , Yamamura K, & Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193199, 1991 Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–199, 1991

    • Search Google Scholar
    • Export Citation
  • 25.

    Nutt JG, , Burchiel KJ, , Comella CL, , Jankovic J, , Lang AE, & Laws ER Jr, et al: Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60:6973, 2003 Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER Jr, et al: Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60:69–73, 2003

    • Search Google Scholar
    • Export Citation
  • 26.

    Olanow CW, , Goetz CG, , Kordower JH, , Stoessl AJ, , Sossi V, & Brin MF, et al: A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54:403414, 2003 Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al: A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54:403–414, 2003

    • Search Google Scholar
    • Export Citation
  • 27.

    Palfi S, , Leventhal L, , Chu Y, , Ma SY, , Emborg M, & Bakay R, et al: Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci 22:49424954, 2002 Palfi S, Leventhal L, Chu Y, Ma SY, Emborg M, Bakay R, et al: Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci 22:4942–4954, 2002

    • Search Google Scholar
    • Export Citation
  • 28.

    Paxinos G, & Watson C: The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press, 1998 Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press, 1998

    • Search Google Scholar
    • Export Citation
  • 29.

    Shingo T, , Date I, , Yoshida H, & Ohmoto T: Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J Neurosci Res 69:946954, 2002 Shingo T, Date I, Yoshida H, Ohmoto T: Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J Neurosci Res 69:946–954, 2002

    • Search Google Scholar
    • Export Citation
  • 30.

    Shingo T, , Sorokan ST, , Shimazaki T, & Weiss S: Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21:97339743, 2001 Shingo T, Sorokan ST, Shimazaki T, Weiss S: Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21:9733–9743, 2001

    • Search Google Scholar
    • Export Citation
  • 31.

    Smith AD, , Antion M, , Zigmond MJ, & Austin MC: Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat. Brain Res Mol Brain Res 117:129138, 2003 Smith AD, Antion M, Zigmond MJ, Austin MC: Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat. Brain Res Mol Brain Res 117:129–138, 2003

    • Search Google Scholar
    • Export Citation
  • 32.

    Toledo-Aral JJ, , Mendez-Ferrer S, , Pardal R, , Echevarria M, & Lopez-Barneo J: Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J Neurosci 23:141148, 2003 Toledo-Aral JJ, Mendez-Ferrer S, Pardal R, Echevarria M, Lopez-Barneo J: Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J Neurosci 23:141–148, 2003

    • Search Google Scholar
    • Export Citation
  • 33.

    Treanor JJ, , Goodman L, , de Sauvage F, , Stone DM, , Poulsen KT, & Beck CD, et al: Characterization of a multicomponent receptor for GDNF. Nature 382:8083, 1996 Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, et al: Characterization of a multicomponent receptor for GDNF. Nature 382:80–83, 1996

    • Search Google Scholar
    • Export Citation
  • 34.

    Ugarte SD, , Lin E, , Klann E, , Zigmond MJ, & Perez RG: Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res 73:105112, 2003 Ugarte SD, Lin E, Klann E, Zigmond MJ, Perez RG: Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res 73:105–112, 2003

    • Search Google Scholar
    • Export Citation
  • 35.

    Wang Y, , Chang CF, , Morales M, , Chiang YH, & Hoffer J: Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann NY Acad Sci 962:423437, 2002 Wang Y, Chang CF, Morales M, Chiang YH, Hoffer J: Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann NY Acad Sci 962:423–437, 2002

    • Search Google Scholar
    • Export Citation
  • 36.

    Winkler C, , Sauer H, , Lee CS, & Bjorklund A: Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 16:72067215, 1996 Winkler C, Sauer H, Lee CS, Bjorklund A: Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 16:7206–7215, 1996

    • Search Google Scholar
    • Export Citation
  • 37.

    Worby CA, , Vega QC, , Zhao Y, , Chao HH, , Seasholtz AF, & Dixon JE: Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J Biol Chem 271:2361923622, 1996 Worby CA, Vega QC, Zhao Y, Chao HH, Seasholtz AF, Dixon JE: Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J Biol Chem 271:23619–23622, 1996

    • Search Google Scholar
    • Export Citation
  • 38.

    Yasuhara T, , Shingo T, , Kobayashi K, , Takeuchi A, , Yano A, & Muraoka K, et al: Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci 19:14941504, 2004 Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, et al: Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease. Eur J Neurosci 19:1494–1504, 2004

    • Search Google Scholar
    • Export Citation
  • 39.

    Yoshida H, , Date I, , Shingo T, , Fujiwara K, , Kobayashi K, & Miyoshi Y, et al: Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study. J Neurosurg 98:874881, 2003 Yoshida H, Date I, Shingo T, Fujiwara K, Kobayashi K, Miyoshi Y, et al: Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a pre-clinical primate study. J Neurosurg 98:874–881, 2003

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 462 114 26
Full Text Views 117 4 0
PDF Downloads 92 3 0
EPUB Downloads 0 0 0